DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,993 filers reported holding DANAHER CORPORATION in Q3 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,216,277 | +4.6% | 8,933 | +1.2% | 1.86% | +8.0% |
| Q2 2023 | $2,118,480 | -22.8% | 8,827 | -19.0% | 1.72% | -10.5% |
| Q1 2023 | $2,745,220 | +1.5% | 10,892 | +6.8% | 1.92% | -12.5% |
| Q4 2022 | $2,705,957 | +2.3% | 10,195 | -0.4% | 2.20% | -2.1% |
| Q3 2022 | $2,644,890 | -49.7% | 10,240 | -50.7% | 2.24% | -5.7% |
| Q2 2022 | $5,261,000 | -21.9% | 20,750 | -9.6% | 2.38% | +2.6% |
| Q1 2022 | $6,734,000 | -15.9% | 22,958 | -5.7% | 2.32% | -4.4% |
| Q4 2021 | $8,008,000 | +9.1% | 24,341 | +1.0% | 2.42% | -8.5% |
| Q3 2021 | $7,337,000 | +13.1% | 24,099 | -0.3% | 2.65% | +6.1% |
| Q2 2021 | $6,487,000 | +10.9% | 24,175 | -6.9% | 2.50% | +5.4% |
| Q1 2021 | $5,847,000 | +0.8% | 25,977 | -0.5% | 2.37% | -3.1% |
| Q4 2020 | $5,800,000 | -3.5% | 26,111 | -6.5% | 2.45% | -11.6% |
| Q3 2020 | $6,011,000 | +12.6% | 27,916 | -7.5% | 2.77% | +2.2% |
| Q2 2020 | $5,337,000 | +31.9% | 30,184 | +3.3% | 2.71% | +8.4% |
| Q1 2020 | $4,045,000 | -9.0% | 29,227 | +0.9% | 2.50% | +12.9% |
| Q4 2019 | $4,446,000 | +6.7% | 28,970 | +0.4% | 2.21% | -0.2% |
| Q3 2019 | $4,166,000 | +0.9% | 28,845 | -0.1% | 2.22% | -4.6% |
| Q2 2019 | $4,128,000 | +28.6% | 28,882 | +18.8% | 2.33% | +10.6% |
| Q1 2019 | $3,210,000 | +41.2% | 24,308 | +10.3% | 2.10% | +17.5% |
| Q4 2018 | $2,273,000 | -6.6% | 22,037 | -1.6% | 1.79% | +7.7% |
| Q3 2018 | $2,434,000 | +17.0% | 22,400 | +6.3% | 1.66% | +3.1% |
| Q2 2018 | $2,080,000 | +1.0% | 21,079 | +0.2% | 1.61% | -12.6% |
| Q1 2018 | $2,059,000 | +9.6% | 21,029 | +3.9% | 1.85% | +14.0% |
| Q4 2017 | $1,879,000 | +11.2% | 20,249 | +2.9% | 1.62% | +5.5% |
| Q3 2017 | $1,689,000 | +3.0% | 19,687 | +1.3% | 1.53% | +1.1% |
| Q2 2017 | $1,640,000 | +1.3% | 19,427 | +2.6% | 1.52% | -0.4% |
| Q1 2017 | $1,619,000 | +11.7% | 18,932 | +1.6% | 1.52% | +7.9% |
| Q4 2016 | $1,450,000 | +0.4% | 18,627 | +1.1% | 1.41% | -0.4% |
| Q3 2016 | $1,444,000 | -29.2% | 18,427 | -8.7% | 1.42% | -19.9% |
| Q2 2016 | $2,039,000 | +7.8% | 20,185 | +1.2% | 1.77% | +5.2% |
| Q1 2016 | $1,892,000 | +3.1% | 19,945 | +0.9% | 1.68% | +0.5% |
| Q4 2015 | $1,836,000 | – | 19,765 | – | 1.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |